Skip to content
Disclosery

FCPM III SERVICES B.V.

Follow

13F filer, CIK 2013410, NAARDEN, Netherlands

FCPM III SERVICES B.V. reported $500,389,258 across 9 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-25-281853

Period
2025-09-30
Reported value
$500M
Holdings
9
Top 10 weight
100%
New
1
Sold out
0

Part of the filer group FCPM III SERVICES B.V.

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
VORnew+379,640$18.5M
REPLadded+248,672$1.04M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
NAMSreduced-1,419,729-$40.4M
RAPTreduced-95,939-$2.47M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001193125-25-281853, largest first. % of portfolio is the value over $500,389,258, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 11,831,461 shares; 2024Q4: 10,597,181 shares; 2025Q1: 10,935,310 shares; 2025Q2: 10,632,113 shares; 2025Q3: 9,212,384 shares 9,212,384$262M52.36%-1,419,729Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,954,069 shares; 2024Q4: 5,462,846 shares; 2025Q1: 5,462,846 shares; 2025Q2: 5,462,846 shares; 2025Q3: 5,462,846 shares 5,462,846$69.1M13.81%0Timeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,677,951 shares; 2024Q4: 9,632,561 shares; 2025Q1: 9,632,561 shares; 2025Q2: 9,632,561 shares; 2025Q3: 9,632,561 shares 9,632,561$65.8M13.15%0Timeline
ASTRIA THERAPEUTICS INCASTRIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 2,872,537 shares; 2025Q1: 3,822,537 shares; 2025Q2: 4,107,537 shares; 2025Q3: 4,107,537 shares 4,107,537$29.9M5.98%0
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,339,961 shares; 2024Q4: 3,452,330 shares; 2025Q1: 3,452,330 shares; 2025Q2: 3,452,330 shares; 2025Q3: 3,452,330 shares 3,452,330$26.7M5.34%0Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 379,640 shares 379,640$18.5M3.7%newTimeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,866,449 shares; 2024Q4: 3,970,668 shares; 2025Q1: 3,909,696 shares; 2025Q2: 3,909,696 shares; 2025Q3: 4,158,368 shares 4,158,368$17.4M3.48%+248,672Timeline
RAPTRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 440,176 shares; 2025Q3: 344,237 shares 344,237$8.88M1.77%-95,939Timeline
ENGNWENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,878,148 shares; 2024Q4: 2,878,148 shares; 2025Q1: 2,878,148 shares; 2025Q2: 2,878,148 shares; 2025Q3: 2,878,148 shares 2,878,148$2.07M0.41%0Timeline

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-25-281853 base2025-11-14acceptance time not in the bulk data set